Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Did the major clinical trials of statins affect prescribing behaviour?

Literature DB >> 11450211

Did the major clinical trials of statins affect prescribing behaviour?

M M Mamdani, J V Tu.

Abstract

Mesh：

Substances：

Year: 2001 PMID： 11450211 PMCID： PMC81155

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

7 in total

Review 1. Are drugs within a class interchangeable?

Authors: C D Furberg; D M Herrington; B M Psaty
Journal: Lancet Date: 1999-10-02 Impact factor: 79.321

2. Time trend analysis and variations in prescribing lipid lowering drugs in general practice.

Authors: C Baxter; R Jones; L Corr
Journal: BMJ Date: 1998-10-24

3. Therapeutic-class wars--drug promotion in a competitive marketplace.

Authors: D A Kessler; J L Rose; R J Temple; R Schapiro; J P Griffin
Journal: N Engl J Med Date: 1994-11-17 Impact factor: 91.245

4. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Authors: P Jones; S Kafonek; I Laurora; D Hunninghake
Journal: Am J Cardiol Date: 1998-03-01 Impact factor: 2.778

5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors:
Journal: Lancet Date: 1994-11-19 Impact factor: 79.321

7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245

7 in total

10 in total

1. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

Authors: Zheng Zhou; Elham Rahme; Michal Abrahamowicz; Jack V Tu; Mark J Eisenberg; Karin Humphries; Peter C Austin; Louise Pilote
Journal: CMAJ Date: 2005-04-26 Impact factor: 8.262

2. Statin use associates with a lower incidence of acute kidney injury after major elective surgery.

Authors: Amber O Molnar; Steven G Coca; Phillip J Devereaux; Arsh K Jain; Abhijat Kitchlu; Jin Luo; Chirag R Parikh; J Michael Paterson; Nausheen Siddiqui; Ron Wald; Michael Walsh; Amit X Garg
Journal: J Am Soc Nephrol Date: 2011-04-14 Impact factor: 10.121

3. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

Authors: Stéphane Bissonnette; Rafik Habib; Fotini Sampalis; Stella Boukas; John S Sampalis
Journal: Can J Cardiol Date: 2006-10 Impact factor: 5.223

Did the major clinical trials of statins affect prescribing behaviour?

Review 1. Are drugs within a class interchangeable?

2. Time trend analysis and variations in prescribing lipid lowering drugs in general practice.

3. Therapeutic-class wars--drug promotion in a competitive marketplace.

4. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

1. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.

2. Statin use associates with a lower incidence of acute kidney injury after major elective surgery.

3. Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

4. Statin wars following coronary revascularization--evidence-based clinical practice?

5. The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.

6. Trends in statin therapy initiation during the period 2000-2010 in Israel.

7. A qualitative study of evidence in primary care: what the practitioners are saying.

8. Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

9. Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis.

10. Evidence-based cardiovascular care in the community: a population-based cross-sectional study.